Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Notable: Non-invasive Device · Open Abdomen (AbCLO) Primary completion date changed from estimate of Dec 31, 2025 to Oct 30, 2026 Tufts Medical CenterNot applicable NCT06242925
  2. Notable: Use of Equity Report Cards to Mitigate Disparities in Emergency Medical Services (EMS) Care for Injured Children Primary completion date changed from estimate of Dec 2025 to Jul 31, 2026 Children's National Research InstituteNot applicable NCT06531421
  3. Notable: Safer Personalised Cancer Treatment Digital Follow-up Primary completion date changed from estimate of Jun 1, 2025 to Dec 30, 2025 Nordlandssykehuset HFNot applicable NCT06476158
  4. Notable: Periodontitis · Osteoarthritis Eligibility criteria changed University of ZagrebNot specified NCT07935421
  5. Notable: Dynamic Relationships Between Estrogen Fluctuations, Sleep, and Psychiatric Complexity Among Adolescent Females With ADHD Start date pushed from Sep 2026 to Dec 2026 Duke UniversityNot specified NCT07805382
  6. Notable: Interventions for Health Behaviors in Hypertensive Patients Primary completion date changed from estimate of May 2025 to Dec 31, 2025 Nanjing Medical UniversityNot applicable NCT06640751
  7. Notable: Web-Based Education on Attitudes and Beliefs About HPV Testing Start date pushed from Nov 1, 2026 to Dec 1, 2026 Sakarya UniversityNot applicable NCT07620795
  8. Notable: Electrical Brain Stimulation for College Students With Short-Form Video Addiction: Effects and Mechanisms Eligibility criteria changed Beijing Normal UniversityNot applicable NCT07931729
  9. Notable: Quality of Life and Economic Repercussions of Combining Proactive Medication Assessment and Electronic Monitoring of Toxicities in Subjects Undergoing Oral Cancer Therapy Primary completion date changed from estimate of Oct 2025 to Oct 7, 2026 Centre Hospitalier Universitaire de NīmesNot applicable NCT05345587
  10. Notable: Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania Start date pushed from Oct 7, 2026 to Dec 1, 2026 Harvard School of Public Health (HSPH)Not applicable NCT07493772
  11. Notable: Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock Start date pushed from Oct 31, 2026 to May 1, 2027 Leipzig Heart Science gGmbHNot applicable NCT07762560
  12. Notable: Perceptions of and Reactions to Sustainability Menu Label Designs Results posted: Nov 16, 2026 Johns Hopkins Bloomberg School of Public HealthNot applicable NCT07214792
  13. Notable: CICAPLAST BAUME B5+ on Rosacea Accompanied by Sensitive Skin Results posted: Nov 16, 2026 Beijing Sino-German Union Cosmetic Institute Co., Ltd.Not applicable NCT07106957
  14. Minor: Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL Trial completed Acerta Pharma BVPhase 3 NCT02475681
  15. Minor: IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine Trial status changed: Not Yet Recruiting → Active, Not Recruiting Sinovac Biotech Co., LtdPhase 3 NCT07416110
  16. Minor: Mesothelin-Targeting Logic-gated CAR T, · Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression Enrollment closed, study ongoing A2 Biotherapeutics Inc.Phase 1/2 NCT06051695
  17. Minor: SIM0278 · Moderate to Severe Atopic Dermatitis Trial status changed: Not Yet Recruiting → Active, Not Recruiting Jiangsu Simcere Pharmaceutical Co., Ltd.Phase 2 NCT07175233
  18. Minor: MAXPIRe · Axatilimab · Idiopathic Pulmonary Fibrosis (IPF) Trial completed Syndax PharmaceuticalsPhase 2 NCT06132256
  19. Minor: RGX-314 Gene Therapy Administered in the Suprachoroidal Space · Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME) Trial completed AbbViePhase 2 NCT04567550
  20. Minor: FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) Trial completed Ferrer Internacional S.A.Phase 2 NCT06355531
  21. Minor: LY4268989 (MORF 057) in Healthy Participants Trial completed Eli Lilly and CompanyPhase 1 NCT07707375
  22. Minor: Research Into the Safety of a New Agent (VT-5006) · and Without Parkinson's Disease Trial completed Vertero TherapeuticsPhase 1 NCT07310264
  23. Minor: IBI3011 Trial completed Innovent Biologics (Suzhou) Co. Ltd.Phase 1 NCT07295496
  24. Minor: Cardiac Performance System (CPS) Trial completed Sensydia CorporationNot specified NCT06870591
  25. Minor: Vimida Trial completed Gaia AGNot applicable NCT06251518